Internationally recognized experts in radiobiology describe herein the effects of tumour radiosensitivity with chemotherapeutic agents as well as combined modality therapy. The book details the current applications of combined modality therapy in a variety of tumour types. It demonstrates the integration of new specific molecular targeted agents into the mutimodality therapy, thus providing a new class of molecular targeted agents for radiation oncologists.

Internationally recognized experts in cancer biology and clinical research review the present status of the multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as the platinum complexes, taxanes, and gemcitabine in the treatment of malignant gliomas, and head and neck cancer. A review of how to integrate new...